USA · PI Dr. Kim · activated
Patients
32
Active
0
Serious AEs
0
Open QA
1
Aged queries
0
Luna users
0
Studies & contracts
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II · study completed · contract executed · 349000 USD
Patients (32)
708-1013 ›
screened
708-1019 ›
completed
708-1032 ›
completed
708-1054 ›
screened
708-1067 ›
screened
708-1084 ›
completed
708-1087 ›
completed
708-1104 ›
screened
708-1158 ›
completed
708-1171 ›
completed
708-1178 ›
withdrawn
708-1184 ›
screened
708-1213 ›
completed
708-1216 ›
completed
708-1236 ›
withdrawn
708-1242 ›
screened
708-1253 ›
completed
708-1272 ›
withdrawn
708-1286 ›
completed
708-1296 ›
completed
708-1297 ›
completed
708-1316 ›
completed
708-1336 ›
completed
708-1342 ›
completed
708-1347 ›
completed
708-1348 ›
completed
708-1352 ›
screened
708-1353 ›
completed
708-1372 ›
completed
708-1378 ›
completed
708-1406 ›
completed
708-1428 ›
completed
Safety — 102 AEs, 0 serious
No serious adverse events.
QA findings (1 open)
open
major
PROTOCOL VIOLATION: PROTOCOL ENTRY CRITERIA NOT MET (subject 708-1372, 2013-05-10)
Visits & payments
Nothing scheduled.
☾ Luna participants
No Luna participants here yet.